Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium hydroxide with different intra-canal vehicles in necrotic teeth with symptomatic apical abscess
IRCT20240828062890N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of calcium hydroxide in dental abscess and apical periodontitis (AP) (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Clinical symptom improvement. Started Oct 2024; status: completed.
02
Drugs
calcium hydroxide
03
Conditions
dental abscessapical periodontitis (AP)
Beyond the preview
Go deeper on IRCT20240828062890N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240828062890N1.